NCT00743587View on ClinicalTrials.gov

A Study To Assess The Ability Of Tramadol, Naproxen And Oxycodone To Affect The Pain Thresholds Of Patients With Osteoarthritis Of The Thumb

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
Osteoarthritis Thumbs
Interventions
DRUG

Placebo

Oral, a double-dummy approach will be used to maintain the blind between active tablet and capsule doses

DRUG

Oxycodone

Oral, 1 x 20mg controlled-release tablets

DRUG

Tramadol

Oral, 2 x 50mg immediate release capsules

DRUG

Naproxen

Oral, 1 x 500mg enteric-coated

Trial Locations (1)

1070

Pfizer Investigational Site, Brussels

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY